About
Dexamethasone for Ocular Delivery
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
8
As Collaborator
2
Total Enrollment
1,834
By Phase
PHASE3: 3PHASE2: 5PHASE2/PHASE3: 1NA: 1
By Status
COMPLETED: 6ACTIVE_NOT_RECRUITING: 3TERMINATED: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06172257Lead Sponsor
A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)
PHASE3Active, not recruiting
401 participants
Started: Mar 15, 2024 · Completed: Apr 30, 2026
NCT06128369Lead Sponsor
Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery
PHASE3Terminated
117 participants
Started: Dec 18, 2023 · Completed: May 9, 2024
NCT05896670Lead Sponsor
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
PHASE2Completed
122 participants
Started: Nov 29, 2023 · Completed: Mar 27, 2024
NCT05608837Collaborator
Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema
PHASE2Active, not recruiting
28 participants
Started: May 26, 2023 · Completed: Sep 30, 2026
NCT05147233Lead Sponsor
A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
PHASE3Completed
241 participants
Started: Jun 24, 2022 · Completed: Jul 3, 2023
Funding History (1)
DRS
May 10, 2023
Locations (1)
Headquarters
Lausanne, Switzerland
Map
Loading map...